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Introduction
Thyroid surgery results in altered function of the thyroid 
gland, corresponding to the extent of resection. The change 
in functionality will manifest biochemically, clinically or 
both ways. This disorder in thyroid function is called Dys-
thyroidism. Biochemical changes can be detected earlier 
than clinical manifestations and are based on the key hor-
monal assays of Thyroid Stimulating Hormone (TSH), Thy-
roxine (T4) and Triiodothyronine (T3).1,2 The sub-clinical or 
pre-clinical patient has a high risk of progressing to clinical 
disease and should be identified and treated early.3 These 
assays are considered the gold standard in assessing and 
predicting functionality of thyroid gland tissue. TSH mea-
surement is the most sensitive,2,4,5 since in the presence of 
an intact hypothalamus-pituitary-thyroid axis, its level will 
change before the free -T4 and free -T3 levels,2,4-7 so it should 
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Background
Defective thyroid functioning is referred to as dysthyroidism. Despite incomplete thyroidectomy or thyroxine supplementation, 
post-thyroidectomy patients may still experience dysthyroidism. Many times, this may be sub - clinical. This study aimed to assess 
the prevalence and pattern of sub-clinical dysthyroidism following thyroid surgery.
Methods
In this prospective cohort study, 40 patients were consecutively recruited following conventional thyroidectomy and followed 
up to 12months. All patients were euthyroid at surgery. At 12 months serum TSH, T4 and T3 levels were measured and the pa-
tients clinically assessed. The prevalence and pattern of dysthyroidism was analysed statistically against the patient demographics, 
clinical and peri-operative variables for significance, using stata version 13. The confidence interval was at 95% and the statistical 
significance at a p-value of <0.05.
Results
The mean age was 44.3 years (M:F= 1: 12.3). 20% of the patients had medical comorbidities. The types of surgery performed were 
sub-total thyroidectomy (55%), near total thyroidectomy (25%) and total thyroidectomy (20%). The prevalence of postoperative 
dysthyroidism was 52.5%. 22.7% of patients who underwent sub-total thyroidectomy had dysthyroidism. Most patients (90%) who 
were on thyroxine supplement (following total or near total thyroidectomy) still developed dysthyroidism (P= 0.017). The type of 
resection done had the greatest significance (P= 0.000). Other factors associated with dysthyroidism albeit non-significantly were 
history of pre-operative hyperthyroidism, middle age (40 - 60 years), and female gender.
Conclusions
The prevalence of dysthyroidism in this cohort was high which may reflect the broader picture among post - thyroidectomy pa-
tients in this setting. Regular biochemical testing in post-thyroidectomy patients is important to identify and correct dysthyroidism 
early. This requires frequent follow-up and accurate dose adjustment, based on objective assessments like weight or body mass 
index.
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be used as the first line test. Conversely, a normal TSH level 
virtually excludes significant thyroid dysfunction. Current 
standards necessitate that laboratories use at least third gen-
eration TSH assays with a functional sensitivity of <0.01mi-
U/L.4,5 Sensitivities of 0.004 mIU/L or <0.002 µIU/ml can be 
achieved with 4th and 5th generation assays respectively,1 for 
detecting much lower levels of TSH, especially for patients 
on suppressive therapy for thyroid cancer.8,9
In addition to surgery, other factors may alter thyroid 
function,1,2,9,10 such as autoimmune antibodies and infections 
causing thyroiditis with attendant hypothyroidism, Graves’ 
disease associated with hyperthyroidism, or genetic anom-
alies leading to thyroxine resistance and TSH-receptor dys-
function.2,6
Presence of interfering antibodies may lead to spurious 
results.2,6 Some drugs do interfere with thyroid function and 
readings.1,2,9,11 Generally, all these factors should be consid-
ered while assessing thyroid dysfunction. Chronic alcohol 
use also reduces thyroid function,12 and obesity is generally 
associated with higher serum TSH and thyroid hormones.13
Timing of the test is equally important; pre-prandial test-
ing (on starved patients) should be avoided as it is associ-
ated with increased incidence of sub-clinical hypothyroid-
ism.1,2,9,14 The biochemical tests should be correlated with the 
clinical picture before drawing a supplementation plan, this 
improves accuracy of diagnosis so that over-treatment or un-
der-treatment is avoided.
This study aimed to assess the prevalence and pattern of 
sub-clinical dysthyroidism following thyroid surgery in our 
setting and thereby establish adequacy of monitoring and 
treatment or supplementation of these patients.
Methods
This was a prospective non-interventional cohort study car-
ried out at Mulago National Referral Hospital, in Uganda. At 
the endocrine surgery unit, among other operations, about 4 
thyroidectomies are carried out per week or ~200 per year.15 
The thyroid conditions operated include multi-nodular goi-
tres, Grave’s disease, thyroid nodules and malignancy.15 All 
patients are euthyroid or corrected to euthyroid state  before 
surgery.
In 2014, 40 patients underwent conventional thyroidectomy, 
with the extent of surgery/type of thyroidectomy determined 
independently by individual patient factors and the handling 
surgeon. After surgery those who consented to participate in 
the study were consecutively recruited. All the patients were 
followed up to the end-point of the study – at 12months. 
During this time, those with intervening problems were 
investigated and managed accordingly. At 12months, the 
patients were assessed for features of hyperthyroidism and 
hypothyroidism and the clinical findings and the thyroid 
hormone profile (TSH, T4 and T3 levels) were documented.
The hormonal assays were done using an ISO certified Cobas 
6000 analyser in the accredited clinical chemistry laborato-
ry of the hospital. Samples were drawn into red-top blood 
collection tubes and delivered to the laboratory within 2hrs. 
Turnaround time was between 5-12hrs dependent on load.
Results analysis: The participants’ demographic data was 
grouped into continuous and categorical variables, and an-
alysed as means and proportions respectively. The patient 
independent variables and the corresponding TFT measure-
ments were tallied and tabulated into contingency tables. 
The prevalence and pattern of dysthyroidism was analysed 
statistically against the patient demographic, clinical and 
peri-operative variables for significance - using Fischer’s Ex-
act Test or Pearson’s chi-square test for the categorical vari-
ables, and independent T-test for the numerical variables, at 
a confidence interval of 95%. The statistical significance was 
at a p-value of <0.05. Statistical analysis package stata version 
13 was used.
Consent to participate in the study was obtained from all 
participants, and ethical approval was granted by the Mulago 
Hospital Ethics Committee.
Results
The study cohort comprised of 40 participants (n=40), 
with a mean age of 44.3years, ranging from 19 – 70years. 
92.5% were female. The most frequently offered surgery was 
sub-total thyroidectomy (55%), followed by near total-(25%) 
and total thyroidectomy (20%). 20% of the patients had 
medical co-morbidities.
A total of 10 (27.8%) patients received thyroxine supple-
mentation soon after surgery or during routine follow-up. 
Of these, only one did not have dysthyroidism at the time 
of study follow-up. In other words, most of the patients 
(90%) who were on thyroxine supplement still developed 
dysthyroidism, and this was significant statistically (P-val-
ue= 0.017). The type of surgery had the greatest significance 
(P-value= 0.000) where by the majority of those who under-
went total or near total thyroidectomy ended up with dysthy-
roidism, despite the fact that most of them had been started 
on thyroxine supplementation soon after surgery. 22.7% of 
those who underwent sub-total thyroidectomy developed 
dysthyroidism, indicating failure of their remnant thyroid 
tissue to regain normal function, which corresponds to 
some reports highlighting the onset of hypothyroidism after 
sub-total thyroidectomy.16
The overall prevalence of dysthyroidism in this cohort 
was high at 52.5% (more than half the participants). Dys-
thyroidism was commonest among the 40-60yr age group 
(Figure 1) probably because they were the biggest age 
group. Notably, a bigger proportion (72.7%) of the young-
er age group (< 40years) had dysthyroidism, while among 
the elderly (> 60years) only 1 out of 5 had dysthyroidism. 
According to gender, dysthyroidism occurred more among 
the females who represented  the great majority of the study 
group. About half of the females, and all males had dysthy-
roidism but this was not statistically significant. Despite be-
ing corrected to euthyroid state before surgery, patients with 
prior hyperthyroidism were more likely to have post-opera-
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Table 1: Characteristics of the study population with regard to dysthyroidism  
      Dysthyroidism  
No Yes Total No Yes Total 
 
 
N N N % % % 
 
Patient age group 
     
<40 3 8 11 27.3 72.7  100 
 
40-<60 11 12 23 47.8 52.2 100 
 
>=60 4 1 5 80 20 100 
 
Total 18 21 39 46.2 53.8 100 
 
Pearson Χ2= 3.909 
     
P-value= 0.142 
      
Gender of the patient 
     
Female 19 18 37 51.4 48.6 100 
 
Male 0 3 3 0 100 100 
 
Total 19 21 40 47.5 52.5 100 
 
Pearson Χ2= 2.934 
     
P-value= 0.087 
      
Medical comorbidities 
     
Yes 6 2 8 75 25 100 
 
No 13 19 32 40.6 59.4 100 
 
Total 19 21 40 47.5 52.5 100 
 
Pearson Χ2= 3.033 
     
P-value= 0.082 
      
Resection done  
     
Sub-total 17 5 22 77.3 22.7 100 
 
Near-total 1 9 10 10 90 100 
 
Total 1 7 8 12.5 87.5 100 
 
Total 19 21 40 47.5 52.5 100 
 
Pearson Χ2= 17.389 
     
P-value= 0.000 
      
Taking thyroxine supplement 
     
Yes 1 9 10 10 90 100 
 
No 14 12 26 53.8 46.2 100 
 
Total 15 21 36 41.7 58.3 100 
 
Pearson Χ2= 5.713 
     
P-value= 0.017 
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tive dysthyroidism (71.4%), but this was also not statistically 
significant.
Only two patients (25%) with medical co-morbidities 
had dysthyroidism but this was statistically  insignificant. 
The type of resection done had great statistical significance, 
with a large percentage of those who had total and near total 
thyroidectomy (90% and 87.5%) respectively, having dysthy-
roidism.
According to Figure 1, the commonest form of dysthy-
roidism was hypothyroidism as depicted by the high TSH 
(blue bar) in the TSH column, this also corresponds to the 
proportionately high number of patients with low T4.
Discussion
This study revealed that the prevalence of sub-clinical 
dysthyroidism in our setting is high (52.5%), indicating that 
despite the lack of overt signs and symptoms, a significant 
number of our post thyroidectomy patients will quietly tran-
sit and slip into clinical dysthyroidism. Notably, a big pro-
portion (72.7%) of the younger age group (< 40years) had 
dysthyroidism, compared to only 20% among the elderly 
(> 60years), which is ironic because young people would be 
expected to have more intact physiology to ensure robust 
thyroid function regeneration. Despite being corrected to 
euthyroid state before surgery, patients with prior hyperthy-
roidism were more likely to have post-operative dysthyroid-
ism (71.4%), but this was not statistically significant. Many 
of these had sub-total thyroidectomy for Grave’s disease 
where the remnant thyroid tissue probably continued to hy-
per function. Though not supported by most international 
guidelines, sub-total instead of total thyroidectomy is still 
offered in such settings where there is concern over the pa-
tients’ ability to afford lifelong thyroxine replacement ther-
apy.
The commonest form of dysthyroidism was hypothy-
roidism, indicating that our patients either delay to start, 
miss out, or are being under-dosed on thyroxine replace-
ments. Another reason may be poor adherence to thyroxine 
therapy prescriptions. Patients should swallow the tablets in 
fasting state,17 and in our setting they are instructed to take it 
early morning before breakfast. The issue of compliance here 
is very pertinent considering that the proportion of dysthy-
roidism among those already on thyroxine supplementation 
was way high, and this was statistically significant (p=0.017). 
Regarding type of surgery, the sub-groups affected most 
were total and near-total thyroidectomy (p=0.000) which 
automatically precipitate hypothyroidism, but both forms 
of dysthyroidism are witnessed here, further revealing that 
while many were being under-supplemented, others were ac-
tually being over supplemented or taking excess thyroxine. 
(see graph 1; T4 column – blue & brown bars). Patients af-
ter incomplete or sub-total thyroidectomy are considered to 
have enough remnant tissue to regain full thyroid function 
after restoration of the hypothalamus-pituitary-thyroid axis 
which should occur in 4 to 8 weeks, so onset of hypo-thy-
roidism indicates significant delay or failure to recover this 
function.16,18,19 The rate, sufficiency or failure of recovery will 
depend on patient specific factors,1,9 like co-morbidities, age 
and sex,16,20 as well as the pre-operative hormonal levels of 
thyrotropin (TSH), thyroglobulin (TG), anti-thyroglobulin 
(ATA), and anti-microsomal antibody (AMA)21 - which are 
all recognised predictors of post-operative hypothyroid-
ism.19,21 This also underscores the fact that sub-total thyroid-
ectomy done with the intention of preserving normal func-
tion is not always rewarding.16 It is important to remember 
that this hypothyroidism can also be caused by a pre- or 
post-operative thyroiditis, among other causes.16,19,21 Con-
versely, a state of hyperthyroidism can also recur or occur 
due to Grave’s disease involving the thyroid remnant.16
Following lobectomy, some studies have reported a 
14.3% incidence of hypothyroidism, requiring thyroxine 
supplementation.19 In other reports the risk of these patients 
developing thyroid insufficiency in their lifetime is higher, 
at 21%21 or up to 28%.19 The onset of overt hypothyroidism 
following surgery is gradual and may be preceded by sub-
clinical hypothyroidism for many years.21 Assessment of thy-
roid function in these patients is recommended four to eight 
weeks after surgery, followed by quarter yearly for the subse-
quent year or 2 years,19 and then annually indefinitely.16,22,23 
However, more frequent monitoring is relevant because pa-
tients regain full thyroid function at different rates, while the 
metabolic demands of others may change from time to time; 
influenced by factors including advancing age, changing na-
ture of work/occupation/lifestyle and concurrent illnesses or 
physiological stress. Those with sub-clinical hypothyroidism 
(elevated TSH) are more likely to progress to clinical hy-
pothyroidism,1,3 so adequate and timely thyroxine replace-
ment should be administered accordingly.19,23 The transitory 
sub-clinical period provides a window of opportunity to do 
the TFTs and identify the dysthyroidism early to prevent 
overt disease.16 Thyroid function tests at the extremes of the 
normal range may indicate early thyroid dysfunction and re-
peat tests are indicated in such situations.1,6,8
In our setting many patients come from distant rural 
communities where qualified medical personnel and com-
petent laboratories are scarce, making frequent monitoring 
very difficult to ensure. Indeed patients cited high transport 
costs and hardships of travelling long distances as limitations 
to medical reviews. There’s also reluctance to request for or 
do laboratory tests more frequently due to financial con-
straints. TFTs cost ~ $25-45, which is a limitation for most 
patients.15
Despite such socio-economic challenges, ensuring ad-
equate and effective thyroxine supplementation among 
post-thyroidectomy patients requires more frequent follow 
up and assessment, accurate hormonal assays, appropriate 
dosing or dose adjustment1,2,16 based on objective need as-
sessments like body weight (mg/kg) and body mass index 
(BMI),24 intense counselling on compliance and closer su-
pervision of those on supplements. Endocrine Unit-based 
dispensing of thyroxine supplements would ensure that 
thorough instructions are passed on.
This study is limited by the small population, so a repeat 
with a bigger sample size would give more valid findings. 
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Possible assay interference was pre-emptied by ensuring 
thorough quality assurance as indicated in the methods, and 
other possible factors interfering with the thyroid function 
like drugs,1,11 alcohol use,9 and obesity13 have been ruled out 
among participants in this study. A study to specifically as-
sess factors influencing compliance to treatment with thy-
roxine among post-thyroidectomy patients in this setting is 
called for.
Conclusions
There is high prevalence of undetected dysthyroidism in 
post-thyroidectomy patients in our centre, and probably our 
broader setting, mainly manifesting as hypothyroidism. A 
significant number of patients seem to be receiving inade-
quate thyroxine treatment. There is need to identify, prevent 
or correct all possible factors affecting adequate supplemen-
tation of post-thyroidectomy patients. These patients should 
be monitored regularly/frequently and offered effective thy-
roxine supplementation doses calculated from objective as-
sessments like weight or BMI.
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